Search Results - "Foster, Kelly D."

Phase I study of novel SYK inhibitor TAK‐659 (mivavotinib) in combination with R‐CHOP for front‐line treatment of high‐risk diffuse large B‐cell lymphoma by Karmali, Reem, St‐Pierre, Frederique, Ma, Shuo, Foster, Kelly D., Kaplan, Jason, Mi, Xinlei, Pro, Barbara, Winter, Jane N., Gordon, Leo I.

“…Background: TAK‐659, a novel oral SYK inhibitor, has demonstrated efficacy in heavily pretreated diffuse large B‐cell lymphoma (DLBCL). We report results of a…”
Get full text

Palliative Care Usage in Young Adult Oncology Population by Foster, Kelly D, Chuzi, Sarah, Beaumont, Jennifer L, Kircher, Sheetal, Smith, Melanie, Sanford, Stacy, Mohindra, Nisha

“…Early integration of palliative care (PC) into adult oncology practice has been shown to improve quality of life and health care utilization; however, little…”
Get more information

ABT-165, a Dual Variable Domain Immunoglobulin (DVD-Ig) Targeting DLL4 and VEGF, Demonstrates Superior Efficacy and Favorable Safety Profiles in Preclinical Models by Li, Yingchun, Hickson, Jonathan A, Ambrosi, Dominic J, Haasch, Deanna L, Foster-Duke, Kelly D, Eaton, Lucia J, DiGiammarino, Enrico L, Panchal, Sanjay C, Jiang, Fang, Mudd, Sarah R, Zhang, Catherine, Akella, Surekha S, Gao, Wenqing, Ralston, Sherry L, Naumovski, Louie, Gu, Jijie, Morgan-Lappe, Susan E

“…Antiangiogenic therapy is a clinically validated modality in cancer treatment. To date, all approved antiangiogenic drugs primarily inhibit the VEGF pathway…”
Get full text

[18F]BTK-1: A Novel Positron Emission Tomography Tracer for Imaging Bruton’s Tyrosine Kinase by Skaddan, Marc B., Wooten, Dustin W., Wilcox, Kyle C., Voorbach, Martin J., Reuter, David R., Jia, Zhaozhong J., Foster-Duke, Kelly D., Hickson, Jonathan A., Vaidyanathan, Srirajan, Reed, Aimee D., Tovcimak, Ann E., Guo, Qi, Comley, Robert A., Lee, Lance, Finnema, Sjoerd J., Mudd, Sarah R.

“…Purpose Bruton's tyrosine kinase (BTK) is a key component of B cell receptor (BCR) signaling, and as such a critical regulator of cell proliferation and…”
Get full text

Breast Imaging Findings in Dermatofibrosarcoma Protuberans: A Case Report and Review of Literature by Pernicone MD, Elizabeth, Fabrega-Foster MD, Kelly

“…Dermatofibrosarcoma protuberans (DFSP) is a rare, indolent, cutaneous sarcoma originating in the dermis, and although nearly half of cases occur on the trunk,…”
Get full text

Phase I Study of Novel SYK Inhibitor TAK-659 in Combination with R-CHOP for Front-Line Treatment of High Risk Diffuse Large B-Cell Lymphoma by Karmali, Reem, Ma, Shuo, Foster, Kelly D, Kaplan, Jason, Palmer, Brett Alan, Mi, Xinlei, Pro, Barbara, Winter, Jane N., Gordon, Leo I.

“…Background: DLBCL is highly heterogeneous in underlying biology and clinical behavior. Several high-risk disease features and poor prognostic factors are…”
Get full text